Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients

Ralph J.F. Manders; Stephan F.E. Praet; Ruth C.R. Meex; René Koopman; André L. De Roos; Anton J.M. Wagenmakers; Wim H.M. Saris; Luc J.C. Van Loon

Journal ArticleOPEN ACCESS

Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients

Diabetes Care (2006) 29(12) 2721-2722

DOI: 10.2337/dc06-1424

71Citations

65Readers

Get full text

Cite

CITATION STYLE

APA

Manders, R. J. F., Praet, S. F. E., Meex, R. C. R., Koopman, R., De Roos, A. L., Wagenmakers, A. J. M., … Van Loon, L. J. C. (2006). Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients. Diabetes Care, 29(12), 2721–2722. https://doi.org/10.2337/dc06-1424

Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients

Cite

Register to see more suggestions